01 /What it is
Liraglutide is a synthetic GLP-1 receptor agonist with a fatty acid side chain that extends its duration of action. It is a prescription medicine in regulated markets and a frequent reference compound in GLP-1 incretin research.
02 /How it works
In research models, Liraglutide is studied as a GLP-1 receptor agonist with extended half life relative to native GLP-1. Its mechanism is investigated in incretin pathway research alongside other GLP-1 analogs.
03 /What researchers explore it for
Researchers have explored Liraglutide in GLP-1 receptor research, in incretin pathway research, and in comparative research alongside newer incretin co agonists.
04 /Safety and interactions
Research interactions of note include overlapping pathway engagement with other GLP-1 receptor agonists and with dual incretin agonists. Liraglutide is also a prescription medicine in regulated markets. Liraglutide is for laboratory research use only and is not for human consumption. Not medical advice. Not intended to diagnose, treat, cure, or prevent any disease.
05 /Research notes
Compound family: GLP-1 receptor agonists. Frequently compared with Semaglutide, Tirzepatide, and Retatrutide. The Apothify library lists Liraglutide for encyclopedia coverage only.
Related peptides
Semaglutide · Tirzepatide · Retatrutide